Table 5.
Identification of the factors correlated with A-FABP in obese patients with type 2 diabetes.
| IL-6 | CRP | IL-17 | A-FABP | BMI | WHR | HOMA-IR | |
|---|---|---|---|---|---|---|---|
| IL-6 | — | ||||||
| CRP | 0.15 | — | |||||
| IL-17 | 0.08 | 0.03 | — | ||||
| A-FABP | 0.20☆ | 0.20☆ | 0.11 | — | |||
| BMI | 0.17 | 0.20☆ | 0.06 | 0.45☆☆ | — | ||
| WHR | 0.16 | 0.19 | 0.08 | 0.34☆ | 0.45☆☆ | — | |
| TG | 0.20☆ | 0.22☆ | 0.04 | 0.41☆☆ | 0.42☆☆ | 0.36☆☆ | |
| HDL-C | −0.20☆ | −0.21☆ | −0.13 | −0.22☆ | −0.25☆☆ | −0.23☆ | |
| HbA1C | 0.252☆☆ | 0.23☆ | 0.15 | 0.56☆☆ | 0.27☆☆ | 0.20☆ | |
| HOMA-IR | 0.26☆☆ | 0.21☆ | 0.14 | 0.36☆ | 0.30☆☆ | 0.22☆ | — |
IL-6: interleukin-6; CRP: C-reactive protein; IL-17: interleukin-17; A-FABP: adipocyte fatty acid-binding protein; BMI: body mass index; WHR: waist hip rate; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; HbA1C: glycated hemoglobin A1C; HOMA-IR: Homeostasis Model Assessment Index of insulin resistance. ☆ P < 0.05, ☆☆ P < 0.01.